financetom
Business
financetom
/
Business
/
Incyte Insider Sold Shares Worth $587,275, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Incyte Insider Sold Shares Worth $587,275, According to a Recent SEC Filing
Jul 7, 2025 2:19 PM

04:47 PM EDT, 07/07/2025 (MT Newswires) -- Vijay K Iyengar, Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy, on July 02, 2025, sold 8,617 shares in Incyte ( INCY ) for $587,275. Following the Form 4 filing with the SEC, Iyengar has control over a total of 37,701 common shares of the company, with 37,701 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/879169/000087916925000072/xslF345X05/wk-form4_1751921008.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rent the Runway Fiscal Q4 Loss Narrows, Revenue Rises; Shares Soar After Hours
Rent the Runway Fiscal Q4 Loss Narrows, Revenue Rises; Shares Soar After Hours
Apr 10, 2024
05:37 PM EDT, 04/10/2024 (MT Newswires) -- Rent the Runway ( RENT ) reported a fiscal Q4 loss late Wednesday of $7.02 per diluted share, compared with the loss of $8.07 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $5.90. Revenue for the quarter ended Jan. 31 rose to $75.8 million from $75.4 million a...
--Codorus Valley Bancorp Keeps Quarterly Cash Dividend at $0.17 a Share, Payable May 14 to Holders as of May 7
--Codorus Valley Bancorp Keeps Quarterly Cash Dividend at $0.17 a Share, Payable May 14 to Holders as of May 7
Apr 10, 2024
05:37 PM EDT, 04/10/2024 (MT Newswires) -- Price: 21.59, Change: -0.08, Percent Change: -0.38 ...
Ars Pharmaceuticals Insider Sold Shares Worth $927,735, According to a Recent SEC Filing
Ars Pharmaceuticals Insider Sold Shares Worth $927,735, According to a Recent SEC Filing
Apr 10, 2024
05:42 PM EDT, 04/10/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, President and CEO, on April 09, 2024, sold 100,000 shares in Ars Pharmaceuticals ( SPRY ) for $927,735. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 10,999,622 shares of the company, with 4,126,822 shares held directly and 6,872,800 controlled indirectly....
Update: US DOJ Files Complaint Against Regeneron Pharmaceuticals for Alleged Fraudulent Drug Price Reporting
Update: US DOJ Files Complaint Against Regeneron Pharmaceuticals for Alleged Fraudulent Drug Price Reporting
Apr 10, 2024
05:41 PM EDT, 04/10/2024 (MT Newswires) -- (Updates with Regeneron's comments in the fifth and sixth paragraphs.) The US Department of Justice on Wednesday filed a complaint against Regeneron Pharmaceuticals ( REGN ) alleging that the company fraudulently manipulated Medicare reimbursement for its drug Eylea. The complaint alleges that the company submitted false average sales price (ASP) reports to Medicare,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved